Peter Fasse is a Principal in the Boston office of Fish & Richardson. His practice emphasizes client counseling and patent prosecution in a wide variety of technologies, with an emphasis on healthcare, medical devices, and other biological and medical fields as well as various “green” technologies. Peter helps clients from start-ups to multinationals to develop competitive worldwide patent strategies and to establish solid and defensible patent portfolios. He performs competitive patent analyses, identifies third-party patent risks, and provides patentability and freedom-to-operate opinions. Peter also has experience in opposing and defending patents before the European Patent Office and in U.S. litigation and post-grant proceedings.
Mr. Fasse has experience in various fields including medical therapeutics, diagnostics, devices, and imaging, microfluidic systems, liquid biopsy, nucleic acid sequence analysis systems and software, cell culturing and bioprocessing, molecular biology, complex biomedical systems, optics, machine tools, and lasers. Specific applications relate to, e.g., cancer antibodies, RNAi and CRISPR therapeutics, engineered AAV systems, microfluidic analysis of circulating tumor and fetal cells, cell-free DNA analysis, next generation sequence analysis, CO2 laser systems, 3D printing, e.g., of tissues, human and bacterial genes and polypeptides, dendritic cell- and DNA- based vaccines, nanoparticle and vector-based delivery of therapeutic agents including AAV delivery of DNA to eye and ear tissues, automated blood analysis systems, nucleic acid probes, tissue engineering, infusion pumps, biochips, laser ablation devices, cellulose processing for ethanol production, CO2 recycling power plants, implantable drug delivery devices and microcapsules, ultrasound probes, wind and solar power, cytokines such as IL-8 and PF4, and diagnostic and therapeutic methods for, e.g., AIDS, cancer, autism, diabetes, psoriasis, and arthritis.
In litigation and European opposition matters, Mr. Fasse has represented clients in a variety of patent infringement suits and trade secret misappropriation cases. Specific subject matter at issue included, e.g., cancer therapeutics (Erbitux), cardiac biomarkers, cell culturing systems, methods of treating arthritis (CTL4Ig), dental implants, hook and loop fastener systems, computer-controlled medical infusion pumps, and fiberglass casting materials.
June 20, 2019
Fish & Richardson Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
October 4th, 2018 | 6:00 pm EDT
Mass Eye and Ear's 9th Annual Sense-ation! Gala
June 14, 2018
Fish Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
December 4th, 2017 | 6:00 pm EST
Terry's Foundation Winter Gala
October 17th, 2017 | 6:00 pm EDT
Massachusetts Eye and Ear: 2017 Sense-ation! Gala
Fish Patent Blog
March 30, 2017
Principal Peter Fasse Featured on Angel Invest Boston Podcast, "Patents in His Blood"
Author: J. Peter Fasse
October 6th, 2016 | 6:00 pm EDT
Massachusetts Eye and Ear: 2016 Sense-ation! Gala
January 13th, 2016
Boston Seminar Series: 2015 Year in Review
February 13th, 2013
Get Ready for the New Rules - A Two-Part Series!
November 12th, 2012
Bio Europe 2012
May 8, 2012
The America Invents Act and Its Importance to Patent Prosecution in the Biotech Sector
January 21, 2009
4th Annual BIO World Congress recap